Ninepoint Cannabis & Alternative Health Series F (NPP5421)
9.193
+0.13
(+1.40%)
CAD |
Dec 09 2025
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 2.58% | 11.41M | 0.56% | 8.29% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 8.757M | -10.74% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund's objective is to achieve growth by investing primarily in equity securities of companies engaged in nutrition, nutraceuticals and new forms of medicines and pharmaceutical solutions (including cannabis). |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Biotechnology |
| Peer Group | Sector Equity |
| Global Macro | Equity Industry Sector |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Ninepoint Partners |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
56
-22.90M
Peer Group Low
148.72M
Peer Group High
1 Year
% Rank:
38
8.757M
-357.30M
Peer Group Low
560.91M
Peer Group High
3 Months
% Rank:
35
-70.79M
Peer Group Low
300.57M
Peer Group High
3 Years
% Rank:
49
-877.11M
Peer Group Low
1.081B
Peer Group High
6 Months
% Rank:
32
-133.13M
Peer Group Low
293.50M
Peer Group High
5 Years
% Rank:
65
-338.29M
Peer Group Low
1.371B
Peer Group High
YTD
% Rank:
--
-276.55M
Peer Group Low
509.27M
Peer Group High
10 Years
% Rank:
79
-187.16M
Peer Group Low
1.837B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 10, 2025.
Asset Allocation
As of October 31, 2025.
| Type | % Net |
|---|---|
| Cash | 4.31% |
| Stock | 86.49% |
| Bond | 7.15% |
| Convertible | 0.00% |
| Preferred | 2.05% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Green Thumb Industries, Inc. | 16.87% | 6.30 | -1.91% |
| Costco Wholesale Corp. | 8.73% | 876.99 | -1.29% |
|
Icanic Brands Co Inc FRN 09-Sep-2027
|
7.15% | -- | -- |
| Cronos Group, Inc. | 5.82% | 2.88 | 7.06% |
| Trulieve Cannabis Corp. | 5.60% | 5.73 | -4.18% |
| Microsoft Corp. | 4.95% | 480.87 | -2.27% |
| Amazon.com, Inc. | 4.67% | 232.05 | 1.81% |
| Glass House Brands, Inc. | 4.52% | 5.86 | -2.98% |
|
USD Cash
|
3.66% | -- | -- |
| Quest Diagnostics, Inc. | 3.37% | 180.08 | 0.26% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP |
|
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1000.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund's objective is to achieve growth by investing primarily in equity securities of companies engaged in nutrition, nutraceuticals and new forms of medicines and pharmaceutical solutions (including cannabis). |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Biotechnology |
| Peer Group | Sector Equity |
| Global Macro | Equity Industry Sector |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Ninepoint Partners |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (12-9-25) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 43 |
| Stock | |
| Weighted Average PE Ratio | 43.86 |
| Weighted Average Price to Sales Ratio | 6.337 |
| Weighted Average Price to Book Ratio | 5.357 |
| Weighted Median ROE | -17.62% |
| Weighted Median ROA | -2.10% |
| ROI (TTM) | -5.46% |
| Return on Investment (TTM) | -5.46% |
| Earning Yield | 0.0284 |
| LT Debt / Shareholders Equity | 0.3473 |
| Number of Equity Holdings | 35 |
| Bond | |
| Yield to Maturity (10-31-25) | -- |
| Effective Duration | -- |
| Average Coupon | -- |
| Calculated Average Quality | -- |
| Effective Maturity | -- |
| Nominal Maturity | -- |
| Number of Bond Holdings | 1 |
As of October 31, 2025
Growth Metrics
| EPS Growth (1Y) | 49.86% |
| EPS Growth (3Y) | 1.26% |
| EPS Growth (5Y) | 0.04% |
| Sales Growth (1Y) | 11.47% |
| Sales Growth (3Y) | 11.21% |
| Sales Growth (5Y) | 28.61% |
| Sales per Share Growth (1Y) | 15.47% |
| Sales per Share Growth (3Y) | 7.78% |
| Operating Cash Flow - Growth Rate (3Y) | 27.10% |
As of October 31, 2025
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:NPP5421.TO", "name") |
| Broad Asset Class: =YCI("M:NPP5421.TO", "broad_asset_class") |
| Broad Category: =YCI("M:NPP5421.TO", "broad_category_group") |
| Prospectus Objective: =YCI("M:NPP5421.TO", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |